Canopy Growth Corporation (TSX: WEED)
Health Care · Pharmaceuticals · CA
CA$1.18
-2.48% today · -48.7% 1Y
Canopy Growth Corporation (TSX: WEED) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $349.86M and employs 1,128 people.
Over the last twelve months the share price has lost 48.7%, trading between 1.17 and 3.28.
Tweenvest scores Canopy Growth Corporation across four factors: quality 51/100, value 63/100, growth 0/100. Its strongest factor is value.
WEED price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $349.86M
- Revenue (TTM)
- $206.77M
- P/E
- —
- EPS
- -0.65
- Dividend yield
- —
- Beta (5Y)
- 2.37
- 52-week high
- CA$3.28
- 52-week low
- CA$1.17
- Avg volume (3M)
- —
- Shares outstanding
- 423.04M
- Employees
- 1,128
- Next earnings
- —
About Canopy Growth Corporation
Canopy Growth Corporation, through its various operating units, is actively involved in the cultivation, marketing, and distribution of cannabis and hemp-derived products. These offerings serve both recreational consumers and medical patients across key markets including Canada, the United States, and Germany. The company's business activities are structured into two main divisions: its global cannabis operations and its diverse portfolio of other consumer goods. Its extensive product line features dried cannabis flower, a variety of extracts and concentrates, beverages, edible gummies, and vaporization products. Canopy Growth commercializes these goods under numerous well-known brands such as Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra. Formed in 2009, the enterprise initially operated as Tweed Marijuana Inc. before adopting its current name, Canopy Growth Corporation, in September 2015. Its principal office is located in Smiths Falls, Canada.
- ISIN
- CA1380357048
- Listed since
- Aug 17, 2010
- Exchange
- The Toronto Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Suzhou Fushilai Pharmaceutical Co., Ltd.SZSE: 301258 | $357.63M | CN¥27.04 | -1.31% |
| Turn Therapeutics Inc.NasdaqGM: TTRX | $357.46M | $11.48 | -4.33% |
| ShanXi C&Y Pharmaceutical Group Co.,LTD.SZSE: 300254 | $356.35M | CN¥9.28 | +0.98% |
| Qinghai Spring Medicinal Resources Technology Co., Ltd.SHSE: 600381 | $352.91M | CN¥4.13 | -1.67% |
| Jilin Jian Yisheng Pharmaceutical Co., Ltd.SZSE: 002566 | $349.82M | CN¥7.08 | +0.28% |
| Deva Holding A.S.IBSE: DEVA | $348.01M | TL85.85 | -3.54% |
| Hainan Huluwa Pharmaceutical Group Co., Ltd.SHSE: 605199 | $347.06M | CN¥5.81 | +1.75% |
| Hubei Guangji Pharmaceutical Co., Ltd.SZSE: 000952 | $343.58M | CN¥6.69 | +1.83% |
Figures last refreshed Oct 11, 2026.